Clinical Trial Update: Lapatinib in Treating Patients With Recurrent and/or Metastatic Adenoid Cystic Cancer or Other Salivary Gland Cancers [Phase 2]

View source ↗

Summary

This ClinicalTrials.gov update reports the results of a Phase 2 trial of lapatinib in patients with recurrent and/or metastatic adenoid cystic carcinoma and oth…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenoid Cystic Carcinoma
• Mucoepidermoid Carcinoma
• Salivary Gland Acinic Cell Carcinoma
• Salivary Gland Adenocarcinoma
• Salivary Gland Carcinoma

Drugs mentioned

• Tykerb (lapatinib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: High-grade Salivary Gland Carcinoma, High-grade Salivary Gland Mucoepidermoid Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2017-04-18